ES2113136T3 - Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion. - Google Patents

Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion.

Info

Publication number
ES2113136T3
ES2113136T3 ES95107106T ES95107106T ES2113136T3 ES 2113136 T3 ES2113136 T3 ES 2113136T3 ES 95107106 T ES95107106 T ES 95107106T ES 95107106 T ES95107106 T ES 95107106T ES 2113136 T3 ES2113136 T3 ES 2113136T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
gemfibrozil
procedure
preparation
theme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95107106T
Other languages
English (en)
Inventor
Pal Dr Fekete
Nee Kohalmi Erzsebet D Fellner
Andrea Sandorfalvy
Denes Bezzegh
Gyorgy Dr Ujfalussy
Nee Hernyes Magdolna Gora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of ES2113136T3 publication Critical patent/ES2113136T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL TEMA PRINCIPAL DEL INVENTO SON UNAS COMPOSICIONES FARMACEUTICAS SOLIDAS ORALES QUE CONTIENEN COMO INGREDIENTE ACTIVO GEMFIBROCILO Y 1 O MAS AGENTE(S) AUXILIARES FARMACEUTICOS CONVENCIONALES Y UN SUPERFICIEACTIVO QUE CONTIENE COMO SUPERFICIACTIVO SULFOSUCCINATO DE SODIO BIS-[2-(ETIL)-HEXIL] EN UNA CANTIDAD ENTRE 0.05 0.5% POR PESO, RELATIVO AL CONTENIDO DE GEMBROCILO DE LA COMPOSICION. OTRO TEMA DEL INVENTO ES UN PROCESO PARA PREPARAR ESTAS COMPOSICIONES.
ES95107106T 1994-05-13 1995-05-12 Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion. Expired - Lifetime ES2113136T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401506A HU212428B (en) 1994-05-13 1994-05-13 Process to prepare pharmaceutical compositions containing gemfibrozyl
US08/441,687 US5726201A (en) 1994-05-13 1995-05-15 Gemfibrozil containing pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2113136T3 true ES2113136T3 (es) 1998-04-16

Family

ID=26318196

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95107106T Expired - Lifetime ES2113136T3 (es) 1994-05-13 1995-05-12 Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion.

Country Status (17)

Country Link
US (1) US5726201A (es)
EP (1) EP0684042B1 (es)
JP (1) JP2934941B2 (es)
AT (1) ATE160938T1 (es)
AU (1) AU1768095A (es)
CA (1) CA2149282A1 (es)
CZ (1) CZ287149B6 (es)
DE (1) DE69501183T2 (es)
ES (1) ES2113136T3 (es)
FR (1) FR2719771B1 (es)
GB (1) GB2291349B (es)
GR (1) GR3025749T3 (es)
HR (1) HRP950268B1 (es)
HU (1) HU212428B (es)
IT (1) IT1274483B (es)
PL (1) PL179806B1 (es)
SK (1) SK279927B6 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
IL155959A0 (en) 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
US6841865B2 (en) * 2002-11-22 2005-01-11 International Rectifier Corporation Semiconductor device having clips for connecting to external elements
WO2005041962A1 (en) * 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4126637A (en) * 1977-06-17 1978-11-21 Warner-Lambert Company Process for the production of 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
EP0475894A1 (en) * 1990-08-27 1992-03-18 Warner-Lambert Company Gemfibrozil formulations
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system

Also Published As

Publication number Publication date
JPH0899875A (ja) 1996-04-16
GR3025749T3 (en) 1998-03-31
JP2934941B2 (ja) 1999-08-16
ITMI950961A1 (it) 1996-11-12
HUT70961A (en) 1995-11-28
SK279927B6 (sk) 1999-05-07
EP0684042A2 (en) 1995-11-29
FR2719771B1 (fr) 1997-01-03
PL179806B1 (pl) 2000-10-31
EP0684042A3 (en) 1996-05-15
HRP950268B1 (en) 1999-02-28
CZ287149B6 (en) 2000-09-13
GB2291349A (en) 1996-01-24
CZ122895A3 (en) 1995-12-13
US5726201A (en) 1998-03-10
SK60595A3 (en) 1996-05-08
IT1274483B (it) 1997-07-17
ATE160938T1 (de) 1997-12-15
AU1768095A (en) 1995-11-23
HRP950268A2 (en) 1997-08-31
CA2149282A1 (en) 1995-11-14
GB2291349B (en) 1998-03-18
ITMI950961A0 (it) 1995-05-12
EP0684042B1 (en) 1997-12-10
HU212428B (en) 1996-06-28
FR2719771A1 (fr) 1995-11-17
DE69501183D1 (de) 1998-01-22
DE69501183T2 (de) 1998-05-07
HU9401506D0 (en) 1994-08-29
GB9509542D0 (en) 1995-07-05
PL308580A1 (en) 1995-11-27

Similar Documents

Publication Publication Date Title
ES2178263T3 (es) Composiciones oftarmologicas que contienen un glicosido cationico y unagente terapeutico anionico.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
MX9207169A (es) Composiciones orales para suprimir olores bucales.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ES2109832T3 (es) Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion
BR0110898A (pt) Composição anidra antiperspirante em bastão
ES2151083T3 (es) Composiciones orales que contienen ondansetron.
TR199700878T1 (xx) Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
ES2113136T3 (es) Composiciones farmaceuticas de gemfibrozil y procedimiento para su preparacion.
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
AR002972A1 (es) Pildoras que tienen una matriz farmaceutica que proporcionan un perfil apropiado de liberacion de la droga, composicion para la preparacion de dichamatriz, proceso para preparar dichas pildoras y formas de dosificacion de dicha composicion.
BR0014440A (pt) Formulações de liberação controlada oral
AR009135A1 (es) Composiciones farmaceuticas, proceso para su preparacion y articulo de manufactura que comprenden dicha composicion.
BR0210063A (pt) Composição estável e uso da mesma
EP1362593A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING DIABETIC NEUROPATHY
PE20011092A1 (es) Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 684042

Country of ref document: ES